BioXcel Therapeutics, Inc. (BTAI) Stock Price, News, Quote

Find the latest BioXcel Therapeutics, Inc. (BTAI) stock quote, history, news and other vital information to help you with your stock trading and investing.

CouponFollow Extension

$127
OFF

BTAI Stock Price | BioXcel Therapeutics Inc. Stock Quote (U.S.: …

6 days from now

4 days ago · BioXcel Therapeutics price target cut to $127 from $150 at Truist Securities, stock rated buy Apr. 1, 2021 at 6:59 a.m. ET by Tonya Garcia BioXcel Therapeutics started at buy …

marketwatch.com

$0.58
OFF

BioXcel Therapeutics Stock Price | BTAI Stock Quote, News, And …

6 days from now

On Wednesday 11/20/2024 the closing price of the BioXcel Therapeutics Inc Registered Shs share was $0.58 on BTT. Compared to the opening price on Wednesday 11/20/2024 on BTT …

businessinsider.com

89%
OFF

BioXcel Therapeutics Inc (BTAI) Q3 2024 Earnings Call Highlights ...

6 days from now

Nov 15, 2024 · BioXcel Therapeutics Inc (NASDAQ:BTAI) reported an 89% increase in net revenue for the nine months ended September 30, 2024, compared to the same period in …

yahoo.com

$7
OFF

BioXcel Therapeutics Announces Pricing Of $7M Public Offering

6 days from now

BioXcel Therapeutics, Inc. (BTAI) Q3 2024 Earnings Call Transcript; BioXcel announces common stock and warrants offering, no amount given; BioXcel Therapeutics GAAP EPS of -$0.32 …

msn.com

$7
OFF

BioXcel Therapeutics Announces Pricing Of $7M Public Offering

6 days from now

1 day ago · BioXcel Therapeutics, Inc. (BTAI) Q3 2024 Earnings Call Transcript BioXcel announces common stock and warrants offering, no amount given BioXcel Therapeutics …

seekingalpha.com

$7
OFF

BioXcel Therapeutics Announces Pricing Of $7.0 Million

6 days from now

1 day ago · NEW HAVEN, Conn., Nov. 22, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (the “Company”) (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial …

globenewswire.com

$7
OFF

BioXcel Therapeutics Announces $7M Public Offering At $0.48 Per …

6 days from now

1 day ago · BioXcel Therapeutics (BTAI) has announced the pricing of a $7.0 million public offering, consisting of 5,600,000 shares of common stock and warrants to purchase up to …

stocktitan.net

$7
OFF

BioXcel Therapeutics Announces Pricing Of $7.0 Million Public …

6 days from now

NEW HAVEN, Conn., Nov. 22, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (the “Company”) (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence …

bioxceltherapeutics.com

FAQs about BioXcel Therapeutics, Inc. (BTAI) Stock Price, News, Quote Coupon?

Who owns bioxcel Therapeutics (btai)?

It also focuses on utilizing technology and research to develop therapeutics solutions. The company was founded by Vimal D. Mehta on March 29, 2017 and is headquartered in New Haven, CT. View BioXcel Therapeutics, Inc. BTAI stock quote prices, financial information, real-time forecasts, and company news from CNN. ...

Who owns bioxcel Therapeutics Inc?

It also focuses on utilizing technology and research to develop therapeutics solutions. The company was founded by Vimal D. Mehta on March 29, 2017 and is headquartered in New Haven, CT. BTAI | Complete BioXcel Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. ...

Does bioxcel Therapeutics (btai) have earnings?

BioXcel Therapeutics, Inc. (NASDAQ:BTAI) reported earnings on Thursday, May, 9th. The company reported ($0.87) EPS, missing analysts' consensus estimates of ($0.68) by $0.19. The business earned $0.58 million during the quarter, compared to the consensus estimate of $0.42 million. ...

Is bioxcel Therapeutics (btai) a hammer chart reversal?

BioXcel Therapeutics (BTAI) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term. ...

Will bioxcel Therapeutics (btai) revert to a trend reversal?

This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term. BioXcel Therapeutics (BTAI) delivered earnings and revenue surprises of 72.37% and 38%, respectively, for the quarter ended June 2024. ...

What is the price target for bioxcel Therapeutics Inc registered SHS (BTT)?

Compared to the opening price on Thursday 08/22/2024 on BTT of $0.67, this is a drop of 2.47%. BioXcel Therapeutics Inc Registered Shs's market capitalization is $27.14 M by 40.74 M shares outstanding. *The average price target includes all analyst analysis, not just the most recent analysis presented in the chart. Selling, General & Admin. Exp. ...